| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/08/2006 | EP1622569A2 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 02/08/2006 | EP1622563A2 Improved heat shock protein-based vaccines and immunotherapies |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1453517B1 Platinum derivative pharmaceutical formulations |
| 02/08/2006 | EP1358162B1 Dihydroindole and tetrahydroquinoline derivatives |
| 02/08/2006 | EP1352052B1 Method for preparing submicron particle suspensions of pharmaceutical agents |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1144348B1 Lta 4 hydrolase inhibitors |
| 02/08/2006 | EP1119362B1 Use of tetracycline derivatives to enhance interleukin-10 production |
| 02/08/2006 | EP1068297B1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency |
| 02/08/2006 | EP0812356B1 Prostate-specific membrane antigen and uses thereof |
| 02/08/2006 | CN1732172A Epothilone derivatives |
| 02/08/2006 | CN1732147A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/08/2006 | CN1732016A Modified cytokines for use in cancer therapy |
| 02/08/2006 | CN1732007A Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy |
| 02/08/2006 | CN1731989A A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 02/08/2006 | CN1731988A Sustained release pharmaceutical composition |
| 02/08/2006 | CN1730665A PI3K enzyme inhibitor quick-speed screening method |
| 02/08/2006 | CN1730658A Recombinant plasmid for curing prostate gland cancer and melanoma |
| 02/08/2006 | CN1730493A Mouse single-chain antibody of anti- nasopharyngeal carcinoma and its DNA sequence |
| 02/08/2006 | CN1730489A Muc1 and C end active fragment mutants, their encoding gene and use thereof |
| 02/08/2006 | CN1730479A Aloe dihydro-coumarin and its separation method and uses |
| 02/08/2006 | CN1730100A Anti-lymphadenoma gene family specificity nucleic acid vaccine combination |
| 02/08/2006 | CN1730099A Immune isolated cell medicine, its preparing process and its application in killing tumours |
| 02/08/2006 | CN1730093A Chinese traditional medicine preparation for treating cancer and application thereof |
| 02/08/2006 | CN1730020A Method for preparing Chinese medicinal formulation for treating tumor |
| 02/08/2006 | CN1730009A Novel drug administering route of ginseng stem and leave general saponin and its preparation process and new indications |
| 02/08/2006 | CN1730003A Marsdenia tenacissima soft capsule and its preparation method |
| 02/08/2006 | CN1729998A Cancer treating |
| 02/08/2006 | CN1729990A Dripping pills of diosgenin and its preparation process |
| 02/08/2006 | CN1240846C Immunity stimulus amlose of bacterial strain from linteus and its application |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240721C Conjugate of lidamycin, monoclonal antibody and its Fab'segment and its application in targeting treatment of colon cancer and other tumors |
| 02/08/2006 | CN1240717C Low-toxicity human interferon-alpha analog |
| 02/08/2006 | CN1240714C Chirality peptide antigen and vaccine composition based on core sequence of mucin 1 |
| 02/08/2006 | CN1240706C Process for producing super critical extracting caterpillar fungus deoxynucleoside |
| 02/08/2006 | CN1240705C Chemotherapy medication-coupler of gem-bis phosphoric acid and synthetic method as well as usage |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/08/2006 | CN1240681C Nitrile derivatives as cathepsin K inhibitors |
| 02/08/2006 | CN1240669C Phytosphingosine derivate with antitumor activity |
| 02/08/2006 | CN1240439C Genetic switch medicine for treating tumor |
| 02/08/2006 | CN1240437C Oral administered self-emulsifying formulations of pyranone proteinase inhibitors |
| 02/08/2006 | CN1240428C Medicine for treating leukaemia |
| 02/08/2006 | CN1240398C Application of active biologics prepared turtle and/or tortoise organs and animal penis in preparing medicine |
| 02/08/2006 | CN1240390C Biologic converted ginseng composition and preparing process thereof |
| 02/08/2006 | CN1240388C Selective estrogen receptor modulator in combination with dehydroepiandrosterone or its derivative |
| 02/08/2006 | CN1240387C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 02/08/2006 | CN1240386C Matrix metal proteinase and tumor necrosis inhibitor |
| 02/08/2006 | CN1240383C Sophoridine soft capsule for curing malignant tumor, its preparation method and purposes |
| 02/08/2006 | CN1240382C Medicine combinations using pyridoindolone derivatives and anticancer agent as base |
| 02/08/2006 | CN1240380C Phase transfer catalyzed glycosidation of an indolocarbazole |
| 02/08/2006 | CN1240375C Preparation of low dosage medicinal composition with uniform distribution and effect |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995261 Treatment of meningitis, septic shock, infections, reperfusion injuries, hepatitis, pancreatitis; bone, autoimmune, viral, and respiratory system disorders; antiinflammatory, antiarthritic, and antitumor agents |
| 02/07/2006 | US6995244 A mutant binding to prolactin receptor through site 1, does not bind through site 2 nor has diminished binding through site 2, and exhibits <1% of unmodified agonist activity; anticarcinogenic, -tumor and metastatis agents; breast/prostate cancer |
| 02/07/2006 | US6995188 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995175 Anticancer agents |
| 02/07/2006 | US6995171 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents |
| 02/07/2006 | US6995164 Methods of treating tumors |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995154 Catalyst for joining, breaking of Dna; antitumor, anticancer agents |
| 02/07/2006 | US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/07/2006 | US6995150 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6995135 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 02/07/2006 | US6995133 invention describes reduced synthesis of IFN alpha 5 in livers of patients with hepatitis C in comparison to healthy livers; demonstrates importance of use of such interferon sub-types in fabricating compositions for treating viral hepatopathies |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 02/07/2006 | US6994863 Pharmaceutical and cosmetic carrier and composition for topical application |
| 02/07/2006 | US6994862 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994853 administering to a cancer patient in a time-staggered manner: autologous or allogeneic tumor cells of the same tumor type each treated to prevent their survival after reinfusion; and intact bispecific and/or trispecific antibodies |
| 02/07/2006 | US6994840 Kit for radiolabeling ligands with yttrium-90 |
| 02/07/2006 | US6994283 Method for pulverizing to fine powder |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/07/2006 | CA2268484C Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 02/07/2006 | CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha. |
| 02/07/2006 | CA2221075C Use of aminoalcohol derivatives in the treatment of liver disease |
| 02/07/2006 | CA2173158C Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 02/07/2006 | CA2137764C Pharmaceutical compositions comprising solutions or dispersions of a staurosporine active ingredient in a saturated polyalkylene glycol glyceride |
| 02/07/2006 | CA2026147C Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 02/02/2006 | WO2006012422A1 Imidazopyrazine as tyrosine kinase inhibitors |
| 02/02/2006 | WO2006012374A1 Substituted aryl-amine derivatives and methods of use |
| 02/02/2006 | WO2006012359A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 02/02/2006 | WO2006011682A1 Method of preserving and transporting lymphocytes |
| 02/02/2006 | WO2006011670A1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| 02/02/2006 | WO2006010859A1 Novel angiogenesis inhibitors and pharmaceutical and cosmetic use thereof |
| 02/02/2006 | WO2005123772A3 Anti-cancer therapy |
| 02/02/2006 | WO2005107782A3 Use of a modulator of gene expression in the treatment of cancer |
| 02/02/2006 | WO2005105833A3 Novel herpes simplex viruses and uses thereof |
| 02/02/2006 | WO2005094899A8 Clusterin antisense therapy for treatment of cancer |
| 02/02/2006 | WO2005001038A3 Recombinant anti-cd30 antibodies and uses thereof |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060025597 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 02/02/2006 | US20060025576 Multivalent antibodies and uses therefor |
| 02/02/2006 | US20060025484 Use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea for treatment of pancreatic carcinomas, soft tissue sarcomas, testicular tumors, lymphomas, thymomas, wilms' tumors, renal carcinomas, melanomas, lung tumors, intracerebral metastases, tumors in the head and neck area and mammary carcinomas |